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Hirschsprung’s disease (HSCR) is characterized by absence of the enteric nervous system in a variable
portion of the distal gut. Affected infants usually present in the days after birth with bowel obstruction.
Despite surgical advances, long-term outcomes remain variable. In the last 2 decades, great advances
have been made in understanding the genes and molecular biological mechanisms that underlie the
disease. In addition, our understanding of normal enteric nervous system development and how motility
develops in the developing fetus and infant has also increased. This review aims to draw these strands
together to explain the developmental and biological basis of HSCR, and how this knowledge may be
used in future to aid children with HSCR.
© 2010 Published by Elsevier Inc.
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Hirschsprung’s disease (HSCR) is the commonest con-
enital gut motility disorder and is characterized by a lack
f ganglion cells (aganglionosis) in a variable length of
istal gut. Affected infants usually present shortly after birth
ith signs of distal intestinal obstruction that are invariably
atal if left untreated. Current definitive treatment involves
urgery to resect the aganglionic bowel segment and “pull-
hrough” and anastomosis of normally innervated (ganglionic)
ut close to the anal margin. Although broadly successful in
he majority of patients, challenges are encountered in the
anagement of children with more extensive aganglionosis
nd those who experience repeated bouts of enterocolitis.1
urthermore, in the long term up to 75% of children will have
ome form of continence or constipation problem, and 10%
ave symptoms sufficiently severe to warrant a permanent
olostomy. Clearly, an understanding of the biological and
evelopmental basis of aganglionosis is extremely relevant
n understanding the reasons for such variability in biolog-
cal presentation and also in formulating novel treatments
Address reprint requests and correspondence: Mr Simon E. Kenny,
epartment of Paediatric Surgery Alder Hey Children’s NHS Foundation
rust Eaton Rd, Liverpool L12 2AP, UK.tE-mail address: simon.kenny@liv.ac.uk.
055-8586/$ -see front matter © 2010 Published by Elsevier Inc.
oi:10.1053/j.sempedsurg.2010.03.004or children with HSCR in future. It has long been noted that
SCR can be familial and also associated with a range of
yndrome conditions. This review will therefore address the
nderlying developmental and biological basis of HSCR
ith particular emphasis on its’ genetic basis.
ncidence and associated anomalies
emographic studies have shown a remarkably constant inci-
ence of HSCR of approximately 1 in 5000 in both hemi-
pheres, although most epidemiologic studies have been con-
ned to the Caucasian Diaspora, and thus there may be as yet
ndefined interracial differences. Evidence for this comes from
Californian survey in which the authors found significant
nterracial differences in incidence of HSCR: 1:10,000 births
n Hispanic subjects, 1:6667 in white subjects, 1:4761 in
lack subjects, 1:3571 in Asian subjects.2 Differing levels
f consanguinity in different populations may explain some
f the differences, but the authors of recent genetic studies
oncerning frequencies of HSCR-associated mutations
oint to different frequencies in different ethnic popula-
3ions. 48
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In the most common, “classical” form of HSCR, agan-
lionosis is restricted to the rectosigmoid region and is
eferred to as “short segment” disease. This variant ac-
ounts for more than 80% of cases. In the remaining
ases, colonic aganglionosis is more extensive and may
nvolve distal small intestine. Total enteric aganglionosis
s both rare and associated with high morbidity and
ortality. There is a strong male gender bias, with male
atients being affected 2 to 4 times more commonly than
emale ones, although this bias is lost in children with
ore extensive aganglionosis.
Important clues as to which genes are involved in HSCR
ave come from the study of the pattern of associated
alformations that occur in 4% to 35% of cases (Table 1).
nowledge of associated anomalies is also important in the
ourse of genetic counseling and because of potentially
eleterious known associations—medullary thyroid carci-
oma as part of multiple endocrine neoplasia syndrome
ype 2 B (MEN2B) is perhaps the best example. One of the
Table 1 Additional anomalies in Hirschsprung’s disease
Anomaly Example
Neural crest-related
anomalies
Sensorineural deafness Congenital central
hypoventilation syndrome
Isolated sensorineural
deafness
Waardenburg syndrome
Cardiovascular skeletal
and limb anomalies
DiGeorge syndrome
Postaxial polydactyly and
heart defect
CRASH syndrome (X–linked
aqueductal stenosis)
Congenital muscular dystrophy
Cleft palate Goldberg Sphrintzen syndrome
DiGeorge syndrome
Systemic anomalies Neurofibromatosis type 1
Multiple endocrine neoplasia
type 2A
Multiple endocrine neoplasia
type 2B
Smith-Lemli Opitz syndrome
Dysautonomias
Other anomalies
Trisomy 21
Microcephaly
Mental retardation
Inguinal hernia
Small bowel atresia
Duodenal atresia
Genital reproductive tract
Undescended testes
Regional anomalies
Rectal stenosis
Anal stenosis
Imperforate anus
Colonic atresiaommonest associated malformations is Down’s syndrome tED
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trisomy 21), which carries a 100-fold greater risk for HSCR
han the normal population.4
As discussed in this article, the enteric nervous system
s of neural crest origin, and hence HSCR is regarded as
neurocristopathy. Therefore, it is unsurprising that it
s associated with other neurocristopathies because fac-
ors affecting the migration of enteric neuroblasts may
ell affect the migration, differentiation, or survival of
ther neural crest derived cells, for example, Shah-Waar-
enburg (WS4).
he role of the enteric nervous
ystem in determining gut motility
ut motility is a complex process mediated by interaction
etween intestinal smooth muscle (SM), “pacemaker”
ells (interstitial cells of Cajal; ICC), and the enteric
ervous system (ENS). Unlike in the heart, intestinal SM
ells are unable to generate rhythmic electrical slow
aves. In the last 2 decades it has been established that
CC are responsible for slow-wave activity in muscle that
an propagate to adjacent muscle.5,6 Although ICC-gen-
rated slow waves result in some contractile activity and
tendency for intestinal contents to be propagated in a
raniocaudal direction, the ENS is essential for more
idespread coordination plus modulation of amplitude
nd frequency of SM contraction to generate the 2 main
ypes of contractions in the gut: segmentation and peri-
taltic waves. Both occur in the absence of extrinsic
nnervation but require an intact myenteric plexus. Co-
onic motility is quite distinct from small intestinal mo-
ility, and regionalization of contractions in different
egions of the colon occurs. ICC-mediated slow-wave
ctivity causes colonic contractions when the depolariza-
ion is of sufficient amplitude. At the end of the gastro-
ntestinal tract sits the internal sphincter, a specialized
hickening of circular SM within the distal rectum. It
aintains a state of tonic contraction thus maintaining
ontinence in association with the external sphincter.
istension of the rectum, typically with feces, results in
n ENS-dependent reflexive relaxation of the sphincter
rectoanal inhibitory reflex). To achieve these functions,
he ENS is extensive and contains a diverse range of
euronal phenotypes characterized by neurotransmitters
nd morphology; see Hao and Young for review.7 The
ritical role of the ENS is illustrated by the obstruction
hat occurs in children with HSCR (in which there is
ongenital absence of the distal ENS): colonic mass
ovements are unable to propagate through the agangli-
nic segment that remains in a tonic state. Furthermore,
he presence of feces in the rectum fails to elicit relax-
tion in the aganglionic anal sphincter, which contributes
o the obstructive picture seen clinically. 105
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nset of gut motility in the
etus, normal, and premature neonates
here is a remarkable paucity of data on the ontogeny of
uman gut motility that reflects the inherent difficulties in
tudying the developing human. By late gestational age,
etal swallowing results in ingestion of amniotic fluid that is
ropagated through the gut.8 Painstaking antenatal ultra-
onographic studies of fetal gut motility demonstrate fetal
astric emptying occurring at 24 weeks and assuming more
ature patterns by term.9 Small intestinal peristalsis is
arely observed before 29 weeks and subjective observation
uggests active waves of small intestinal peristalsis are
nfrequently seen before 35 weeks of gestation.10 Similarly,
ltrasound studies on human fetal internal sphincter devel-
pment suggest that rhythmic contractions commence in the
hird trimester.11 Preterm infants appear to manifest similar
atterns of onset of gastrointestinal motility, exhibiting
arkedly delayed gastrointestinal transit times when com-
ared with adults. In the small intestine of preterm children,
isorganized peristalsis is seen before the third trimester,
ith migrating motor complexes being observed in human
mall intestine after 33 weeks of gestation.12
There is a marked lack of data on colonic motility in
uman preterms. Some evidence can be gleaned from ani-
al studies in that, in common with humans, intestinal
ontents are propagated through the bowel before birth. The
uthors of recent studies suggest that effective colonic con-
ractions do occur but that these are not mediated by the
NS.13,14 Taken together, in both animals and humans al-
hough the main components regulating gut motility are
resent by 14 weeks of gestation, it seems likely that the
NS is relatively quiescent until late in gestation and gut
otility is controlled by other factors, such as ICC. This
xplains our failure to detect HSCR antenatally as if the
olonic ENS is not functional until birth no bowel dilatation
ill be detected on ultrasound. This is also seen clinically,
n that invariably the abdominal distension is progressive
fter birth rather than being clinically detectable at the
oment of birth.
eural crest origin of the
nteric nervous system and the
athogenesis of Hirschsprung’s disease
eural crest ablation studies and chick-quail chimaera ex-
eriments have shown that ENS neurons and glia are de-
ived from the vagal segment of the neural crest.15,16 Va-
ally derived neural crest cells (NCCs) migrate along the
ourse of the vagus nerves, enter the foregut mesenchyme,
nd spread in a craniocaudal direction throughout the gas-
rointestinal tract. In humans the process takes 7 weeks,
ith neural crest derivatives entering the foregut at 5 weeks,
eaching the distal ileum by 7 weeks, the midcolon by 8
eeks, but taking a further 4 weeks to reach the distal pED
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F
ectum.17,18 This slowing in rate of colonization of the distal
ut is caused by growth of the bowel rather than a reduction
n velocity of migration. In mammals, there is an additional
acral contribution to the colonic ENS but migration of
acral crest cells follows vagal neural crest colonization and
hese cells in isolation are insufficient in isolation to rescue
he HSCR phenotype.19
The vagal sourced NCCs in the distal rectum migrate
urther than any other cells during embryogenesis. It is
herefore not surprising that factors affecting proliferation,
urvival, migration, or differentiation of NCCs results in
ganglionosis of the distal gut. Although important ad-
ances have been made in identifying the complex genetic
icture in HSCR, unraveling the biological mechanisms that
revail in normal neural crest colonization of the gut, and
ow this goes wrong in HSCR has been a formidable tech-
ical challenge because of the inaccessibility of the devel-
ping bowel and the lack of reliable in vivo markers.
Mathematical modeling coupled with experimental ma-
ipulation of chick-quail chimaeras of gut explants suggest
hat cell proliferation at the vanguard of migrating NCC
rives colonization of aganglionic gut with HSCR, resulting
rom discordance between the rate of cell proliferation and
longation by growth of the developing gut.20,21 In recent
ears, the use of the green fluorescent protein gene as a
eporter of NCC expression in explanted mammalian and
vian embryonic gut cultures, or in translucent zebrafish, in
ombination with time-lapse photography has allowed the
attern of neural crest migration and ENS formation to be
etter understood. Furthermore, experimental manipulation
f the embryonic gut environment and gene expression has
llowed insights into the pathogenesis of aganglionosis.
hat has emerged is a complex spatiotemporal interaction
etween migrating cells, developing neurons, and the gut.
Assumptions about the actions of genes made from iso-
ated neural crest cells in vitro have been found wanting as
ells respond to the same cues differently according to their
ocation in the gut and gestational age. Chains of immature
euroblasts migrate through the developing gut and leave a
caffold that subsequent cells follow. This migration has
een shown to be directionally driven by noncanonical Wnt
ignaling, causing contact inhibition;22 although unpredict-
ble at a single cell level, this seems stereotyped at the organ
evel. In particular, a single chain of cells appear to extend
long the mesenteric border of the cecum well in advance of
he rest of the advancing wave of colonization.23 There is
ome evidence that migrating cells may be routed along the
eveloping vasculature.24 Migrating cells have been shown
o undergo cell division to increase cell numbers. Further-
ore, apoptotic control mechanisms may control the final
euronal density in the gut because inhibition of apoptosis
uring NCC colonization results in hyperganglionosis.25
nly a small proportion of migrating cells express neuronal
arkers and these migrate more slowly.26 Increasing cell
aturation as reflected by expression of neuronal or glialhenotype and subsequent neurotransmitter expression is 162
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ssociated with loss of migratory ability.26 Microenviron-
ental factors in the noninnervated colon, such as overex-
ression of laminin, have been suspected to be implicated in
he pathogenesis of HSCR27,28 and documented in the agan-
lionic colon of children with HSCR.29 In support of these
bservations, recent gut explant experiments point to age-
ependent changes in the gut resulting in restriction of NCC
igration into older bowel.30,31 Clearly in HSCR, several
enetic and environmental factors interact to result in failure
f colonization of the distal intestine (see the section
Hirschsprung’s disease and genes”).
A variety of experiments in which small numbers of
eural crest-derived cells were cultured in aganglionic bowel
as demonstrated that relatively small numbers of these cells
an engage in extensive colonization and formation of both
eurons and glia expressing a range of phenotypic markers and
xpressing appropriate neurotransmitters.32,33 Such observa-
ions point to the existence of a reservoir of “stem-cells” within
he migrating wave: cells with extensive proliferative and
ifferentiative capacity. As will be discussed later, the ex-
stence of these cells may point to a future stem-cell based
herapy for HSCR. It should be remembered that at the same
ime as NCC are migrating and colonizing the gut the gut is
aturing in many ways that will impact on future motility.
M and ICC are differentiating from mesenchyme and later
n gestation functional connections are forming between
eurones, ICC, and SM (for review, consult Burns et al32).
irschsprung’s disease and genes
SCR is a complex genetic disease with a low, sex-depen-
ent penetrance (frequency of mutation carriers who have
SCR) and variability in the length of the aganglionic
egment (for review, see Tam and Garcia-Barcelo33 and
rnold et al36). The genetic diversity observed in HSCR can
e attributed to the cascade of molecular and cellular events
hat take place during the ENS development as outlined
bove. Disruption of coding sequences resulting in func-
ional changes to gene products of any of the genes respon-
ible for neural crest cell migration, proliferation, differen-
iation, survival or that alter the permissive environment for
CC migration holds the potential for failure of ENS de-
elopment resulting in HSCR (Table 2). The HSCR pheno-
ype may result from mutations in single or multiple genes.
he existence of individuals with major HSCR-causing mu-
ations who do not manifest the disease underlines the
omplex multigenic mechanisms of ENS formation and also
otentially the role played by environmental factors.
Furthermore, the existence of an overrepresentation of
utations and/or SNPs in gene-receptor complexes, such as
et-GDNF and/or 3rd edn/ENDRB,34,35 when compared
ith controls suggests subtle influences of both major gene-
eceptor complexes in determining HSCR susceptibility.
he role of identified genes in shaping the demographic dED
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F
resentation of HSCR is also beginning to be understood.
or example, an association between RET and chromosome
1 gene dosage has recently been described.36 The male
reponderance observed in isolated short-segment HSCR
ay potentially be explained by the recent finding of re-
uced levels of ECE-1 and endothelin-3 mRNA in normal
ale mouse bowel versus females.37 In the same report,
omparison of male versus female cultured explanted bowel
rom heterozygous mice with a RetDN mutation (showing
educed but not absent Ret activity) showed reduced colo-
ization in male mice. Supplementation of male cultured
owel with endothelin-3 peptide resulted in a significant
ncrease in the rate of bowel colonization. Thus, there is
ncreasing evidence that sex-related differences in endothe-
in-3 expression, on a background of genetic susceptibility,
ay account for the male overrepresentation in HSCR.
odifying genes and
nteraction between signaling pathways
s indicated previously, the successful colonization of the
ut by the ENS precursors depends on the network of
nteracting molecules. Conceivably, there should be a func-
ional and genetic link among these molecules for them to
nteract. Interaction between pathways requires not only
oordination among the pathway members but also with
hose molecules that mediate their interaction. There is
ncreasing evidence of interactions between genes in appar-
ntly different signaling pathways.33
irschsprung’s disease and stem cells
he discovery of a subset of cells with significant proliferative
nd differentiative capacity within the migrating wave of
CCs has given rise to the hope that these cells could poten-
ially represent enteric nervous system stem cells (ENSC).
tem cells are characterized by their capacity for asymmet-
ic cell division, both self-renewing and producing daughter
ells that have the ability to proliferate and form a range of
ell types. Putative ENSCs should therefore be demonstra-
ly immortal, clonal, and capable of proliferating to form
eurons and glia. That these properties have been demon-
trated in mouse NCC strongly supports the existence of
NSCs.38–43 More recently, human ENSCs have been iso-
ated from children and adults with and without HSCR that
an be numerically expanded in vitro and transplanted into
nimal models of HSCR where they have proliferated and
ormed neurons and glia.38,44,45 Furthermore, neuronal
unction has been demonstrated.14
These results appear promising for future clinical appli-
ations. Nevertheless significant obstacles remain. The be-
avior of human ENSCs in the more mature environment of
he neonatal gut needs to be assessed and a robust repro-
ucible and safe form of ENSC transplantation into the right 219
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nvironment developed. Furthermore, long-term studies are
ecessary to demonstrate the genomic stability of trans-
lanted cells to assess potential tumor risk. In addition,
echniques that permit in vivo tracking of transplanted
NSC by the use of such technologies as green fluorescent
rotein labeling or stable integration of nanoparticles, such
s superparamagnetic iron oxide nanoparticles within animal
odels is essential to understand the potential of ENSCs to
igrate beyond the bowel.
In conclusion, the last 2 decades have yielded huge
dvances in our understanding of the developmental and
iological basis of Hirschsprung’s disease and gut motility
n general. Significant challenges remain but increasing
nderstanding of this subject may lead to prediction of
SCR risk and potentially to new treatments and improved
utcomes for this condition.
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